Synageva Biopharma announces pricing of public offering of common stock

06-03-2014 Business Wire HealthComments (0)

BiotechnologyPharmaceuticalSynageva BioPharmaUSA

Synageva BioPharma (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare disorders, today announced the pricing of its previously announced underwritten public offering of common stock consisting of 2.0 million shares at $105.75 per share. In connection with this offering, Synageva granted to the underwriters a 30-day option to purchase 300,000 additional shares of common stock. If the underwriters exercise this

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top